Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22.

Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, Jenkins R, Le Marchand L, Casey G, Haile R, Hopper J, Jenkins M, Young J, Buchanan D, Gallinger S, Adams M, Lewis S, Willis J, Elston R, Markowitz SD, Wiesner GL.

Cancer Res. 2010 Jul 1;70(13):5409-18. doi: 10.1158/0008-5472.CAN-10-0188. Epub 2010 Jun 15.

2.

Sessile serrated adenomas strongly predispose to synchronous serrated polyps in non-syndromic patients.

Pai RK, Hart J, Noffsinger AE.

Histopathology. 2010 Apr;56(5):581-8. doi: 10.1111/j.1365-2559.2010.03520.x.

PMID:
20459568
3.

Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer.

Buchanan DD, Roberts A, Walsh MD, Parry S, Young JP.

Future Oncol. 2010 Apr;6(4):539-49. doi: 10.2217/fon.10.16. Review.

4.

Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer.

Middeldorp A, Jagmohan-Changur SC, van der Klift HM, van Puijenbroek M, Houwing-Duistermaat JJ, Webb E, Houlston R, Tops C, Vasen HF, Devilee P, Morreau H, van Wezel T, Wijnen J.

Genes Chromosomes Cancer. 2010 Jun;49(6):539-48. doi: 10.1002/gcc.20763.

PMID:
20222047
5.

Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.

Walsh MD, Buchanan DD, Cummings MC, Pearson SA, Arnold ST, Clendenning M, Walters R, McKeone DM, Spurdle AB, Hopper JL, Jenkins MA, Phillips KD, Suthers GK, George J, Goldblatt J, Muir A, Tucker K, Pelzer E, Gattas MR, Woodall S, Parry S, Macrae FA, Haile RW, Baron JA, Potter JD, Le Marchand L, Bapat B, Thibodeau SN, Lindor NM, McGuckin MA, Young JP.

Clin Cancer Res. 2010 Apr 1;16(7):2214-24. doi: 10.1158/1078-0432.CCR-09-3058. Epub 2010 Mar 9.

6.

Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study.

Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, Gattas M, Walsh MD, Clendenning M, McKeone D, Walters R, Roberts A, Young A, Hampel H, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Young GP, Chow E, Parry S, Woodall S, Tucker K, Muir A, Field M, Greening S, Gallinger S, Green J, Woods MO, Spaetgens R, de la Chapelle A, Macrae F, Walker NI, Jass JR, Young JP.

Int J Colorectal Dis. 2010 Jun;25(6):703-12. doi: 10.1007/s00384-010-0907-8. Epub 2010 Mar 6. Erratum in: Int J Colorectal Dis. 2010 Dec;25(12):1513-5.

7.

Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas.

Pai RK, Mackinnon AC, Joseph L, Noffsinger A, Hart J.

Am J Surg Pathol. 2010 Mar;34(3):355-63. doi: 10.1097/PAS.0b013e3181c6b9dd.

PMID:
20118768
8.

Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening.

Poynter JN, Siegmund KD, Weisenberger DJ, Long TI, Thibodeau SN, Lindor N, Young J, Jenkins MA, Hopper JL, Baron JA, Buchanan D, Casey G, Levine AJ, Le Marchand L, Gallinger S, Bapat B, Potter JD, Newcomb PA, Haile RW, Laird PW; Colon Cancer Family Registry Investigators.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3208-15. doi: 10.1158/1055-9965.EPI-08-0512.

9.

Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis.

Neklason DW, Kerber RA, Nilson DB, Anton-Culver H, Schwartz AG, Griffin CA, Lowery JT, Schildkraut JM, Evans JP, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Finkelstein DM, Nadkarni PM, Kasten CH, Mineau GP, Burt RW.

Cancer Res. 2008 Nov 1;68(21):8993-7. doi: 10.1158/0008-5472.CAN-08-1376.

10.

The TRAIL apoptotic pathway in cancer onset, progression and therapy.

Johnstone RW, Frew AJ, Smyth MJ.

Nat Rev Cancer. 2008 Oct;8(10):782-98. doi: 10.1038/nrc2465. Review.

PMID:
18813321
11.

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A.

J Clin Oncol. 2008 Dec 10;26(35):5783-8. doi: 10.1200/JCO.2008.17.5950. Epub 2008 Sep 22.

12.

Deciphering the genetics of hereditary non-syndromic colorectal cancer.

Papaemmanuil E, Carvajal-Carmona L, Sellick GS, Kemp Z, Webb E, Spain S, Sullivan K, Barclay E, Lubbe S, Jaeger E, Vijayakrishnan J, Broderick P, Gorman M, Martin L, Lucassen A, Bishop DT, Evans DG, Maher ER, Steinke V, Rahner N, Schackert HK, Goecke TO, Holinski-Feder E, Propping P, Van Wezel T, Wijnen J, Cazier JB, Thomas H, Houlston RS, Tomlinson I; CORGI Consortium.

Eur J Hum Genet. 2008 Dec;16(12):1477-86. doi: 10.1038/ejhg.2008.129. Epub 2008 Jul 16.

13.

Frizzled-7 as a potential therapeutic target in colorectal cancer.

Ueno K, Hiura M, Suehiro Y, Hazama S, Hirata H, Oka M, Imai K, Dahiya R, Hinoda Y.

Neoplasia. 2008 Jul;10(7):697-705.

14.

Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study.

Pendergrass CJ, Edelstein DL, Hylind LM, Phillips BT, Iacobuzio-Donahue C, Romans K, Griffin CA, Cruz-Correa M, Tersmette AC, Offerhaus GJ, Giardiello FM.

Clin Gastroenterol Hepatol. 2008 Sep;6(9):1011-5. doi: 10.1016/j.cgh.2008.03.022. Epub 2008 Jun 16.

15.

The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.

Kodach LL, Wiercinska E, de Miranda NF, Bleuming SA, Musler AR, Peppelenbosch MP, Dekker E, van den Brink GR, van Noesel CJ, Morreau H, Hommes DW, Ten Dijke P, Offerhaus GJ, Hardwick JC.

Gastroenterology. 2008 May;134(5):1332-41. doi: 10.1053/j.gastro.2008.02.059. Epub 2008 Mar 4.

PMID:
18471510
16.

Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q.

Picelli S, Vandrovcova J, Jones S, Djureinovic T, Skoglund J, Zhou XL, Velculescu VE, Vogelstein B, Lindblom A.

BMC Cancer. 2008 Apr 1;8:87. doi: 10.1186/1471-2407-8-87.

17.

CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.

Pittman AM, Broderick P, Sullivan K, Fielding S, Webb E, Penegar S, Tomlinson I, Houlston RS.

Br J Cancer. 2008 Apr 22;98(8):1434-6. doi: 10.1038/sj.bjc.6604314. Epub 2008 Mar 25.

18.

Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study.

Daley D, Lewis S, Platzer P, MacMillen M, Willis J, Elston RC, Markowitz SD, Wiesner GL.

Am J Hum Genet. 2008 Mar;82(3):723-36. doi: 10.1016/j.ajhg.2008.01.007. Epub 2008 Feb 28.

19.

A promoter polymorphism in the CASP8 gene is not associated with cancer risk.

Haiman CA, Garcia RR, Kolonel LN, Henderson BE, Wu AH, Le Marchand L.

Nat Genet. 2008 Mar;40(3):259-60; author reply 260-1. doi: 10.1038/ng0308-259. No abstract available.

PMID:
18305469
20.

Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D; Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2331-43. Epub 2007 Nov 2.

Supplemental Content

Support Center